FDA Inspection 1234874 — Baton Rouge General Medical Center
The FDA completed an inspection of Baton Rouge General Medical Center on March 20, 2024 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 20, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Baton Rouge, LA (United States)